Logo image of DUOT

DUOS TECHNOLOGIES GROUP INC (DUOT) Stock Fundamental Analysis

NASDAQ:DUOT - US2660424076 - Common Stock

6.6 USD
-0.11 (-1.64%)
Last: 9/8/2025, 12:20:11 PM
Fundamental Rating

1

DUOT gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 280 industry peers in the Software industry. DUOT has a bad profitability rating. Also its financial health evaluation is rather negative. DUOT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year DUOT has reported negative net income.
DUOT had a negative operating cash flow in the past year.
DUOT had negative earnings in each of the past 5 years.
In the past 5 years DUOT always reported negative operating cash flow.
DUOT Yearly Net Income VS EBIT VS OCF VS FCFDUOT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

DUOT has a Return On Assets of -33.42%. This is in the lower half of the industry: DUOT underperforms 76.43% of its industry peers.
The Return On Equity of DUOT (-219.87%) is worse than 82.14% of its industry peers.
Industry RankSector Rank
ROA -33.42%
ROE -219.87%
ROIC N/A
ROA(3y)-56.91%
ROA(5y)-67.89%
ROE(3y)-284.96%
ROE(5y)-396.89%
ROIC(3y)N/A
ROIC(5y)N/A
DUOT Yearly ROA, ROE, ROICDUOT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K 1.5K

1.3 Margins

With a Gross Margin value of 22.24%, DUOT is not doing good in the industry: 80.71% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of DUOT has declined.
DUOT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-32.94%
DUOT Yearly Profit, Operating, Gross MarginsDUOT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

0

2. Health

2.1 Basic Checks

DUOT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DUOT has more shares outstanding
The number of shares outstanding for DUOT has been increased compared to 5 years ago.
The debt/assets ratio for DUOT is higher compared to a year ago.
DUOT Yearly Shares OutstandingDUOT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
DUOT Yearly Total Debt VS Total AssetsDUOT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of -1.59, we must say that DUOT is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of DUOT (-1.59) is worse than 75.71% of its industry peers.
DUOT has a Debt/Equity ratio of 0.37. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.37, DUOT is not doing good in the industry: 62.14% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Altman-Z -1.59
ROIC/WACCN/A
WACC11.12%
DUOT Yearly LT Debt VS Equity VS FCFDUOT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M

2.3 Liquidity

A Current Ratio of 0.37 indicates that DUOT may have some problems paying its short term obligations.
DUOT has a worse Current ratio (0.37) than 92.86% of its industry peers.
DUOT has a Quick Ratio of 0.37. This is a bad value and indicates that DUOT is not financially healthy enough and could expect problems in meeting its short term obligations.
DUOT has a worse Quick ratio (0.33) than 93.57% of its industry peers.
Industry RankSector Rank
Current Ratio 0.37
Quick Ratio 0.33
DUOT Yearly Current Assets VS Current LiabilitesDUOT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

5

3. Growth

3.1 Past

DUOT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 35.54%, which is quite impressive.
DUOT shows a strong growth in Revenue. In the last year, the Revenue has grown by 172.93%.
DUOT shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -11.80% yearly.
EPS 1Y (TTM)35.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30.23%
Revenue 1Y (TTM)172.93%
Revenue growth 3Y-4.12%
Revenue growth 5Y-11.8%
Sales Q2Q%279.74%

3.2 Future

DUOT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 42.19% yearly.
The Revenue is expected to grow by 117.51% on average over the next years. This is a very strong growth
EPS Next Y62.11%
EPS Next 2Y42.19%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year228.83%
Revenue Next 2Y117.51%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
DUOT Yearly Revenue VS EstimatesDUOT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M
DUOT Yearly EPS VS EstimatesDUOT Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -2 -4 -6 -8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

DUOT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 215.69, which means the current valuation is very expensive for DUOT.
Based on the Price/Forward Earnings ratio, DUOT is valued a bit more expensive than the industry average as 63.57% of the companies are valued more cheaply.
The average S&P500 Price/Forward Earnings ratio is at 22.66. DUOT is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 215.69
DUOT Price Earnings VS Forward Price EarningsDUOT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150 200

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DUOT Per share dataDUOT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
DUOT's earnings are expected to grow with 42.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.19%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DUOT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DUOS TECHNOLOGIES GROUP INC

NASDAQ:DUOT (9/8/2025, 12:20:11 PM)

6.6

-0.11 (-1.64%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-14 2025-08-14/amc
Earnings (Next)11-17 2025-11-17
Inst Owners22.21%
Inst Owner Change13.36%
Ins Owners22.4%
Ins Owner Change0.32%
Market Cap128.11M
Analysts82.5
Price Target12.75 (93.18%)
Short Float %3.17%
Short Ratio1.69
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-17.42%
Min EPS beat(2)-36.8%
Max EPS beat(2)1.96%
EPS beat(4)2
Avg EPS beat(4)-10.42%
Min EPS beat(4)-36.8%
Max EPS beat(4)29.41%
EPS beat(8)3
Avg EPS beat(8)-20.7%
EPS beat(12)5
Avg EPS beat(12)-22.26%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)13.26%
Min Revenue beat(2)12.9%
Max Revenue beat(2)13.61%
Revenue beat(4)3
Avg Revenue beat(4)-2%
Min Revenue beat(4)-47.91%
Max Revenue beat(4)13.61%
Revenue beat(8)4
Avg Revenue beat(8)-12.85%
Revenue beat(12)5
Avg Revenue beat(12)-14.94%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)8.7%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-50%
EPS NY rev (1m)0%
EPS NY rev (3m)-38.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)11.68%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 215.69
P/S 8.33
P/FCF N/A
P/OCF N/A
P/B 27.07
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.07
EYN/A
EPS(NY)0.03
Fwd EY0.46%
FCF(TTM)-0.5
FCFYN/A
OCF(TTM)-0.38
OCFYN/A
SpS0.79
BVpS0.24
TBVpS-0.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -33.42%
ROE -219.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.24%
FCFM N/A
ROA(3y)-56.91%
ROA(5y)-67.89%
ROE(3y)-284.96%
ROE(5y)-396.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-32.94%
F-Score4
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 66.09%
Cap/Sales 15.21%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.37
Quick Ratio 0.33
Altman-Z -1.59
F-Score4
WACC11.12%
ROIC/WACCN/A
Cap/Depr(3y)127.01%
Cap/Depr(5y)141.85%
Cap/Sales(3y)14.73%
Cap/Sales(5y)10.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30.23%
EPS Next Y62.11%
EPS Next 2Y42.19%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)172.93%
Revenue growth 3Y-4.12%
Revenue growth 5Y-11.8%
Sales Q2Q%279.74%
Revenue Next Year228.83%
Revenue Next 2Y117.51%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year103.24%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y12.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.36%
OCF growth 3YN/A
OCF growth 5YN/A